Significant attrition at each step of the HIV care 'cascade' in British Columbia
Short course of ART during primary HIV infection has immunological and virological benefits after treatment is stopped
For women, HIV treatment based on atazanavir/ritonavir involves twice the risk of failure compared to efavirenz-containing therapy
Systematic review and meta-analysis shows equivalence of 3TC and FTC
Ensuring good-quality HIV care in Europe: where can we improve?
New EACS treatment guidelines strike balance between individual choice and public health, say writers
"If I am given antiretrovirals I will think I am nearing the grave" – a challenge for early treatment strategies
Raltegravir appears safe for mothers and babies during pregnancy
